Eastman Chemical Company
EMN NYSEBasic Materials ★★★★★Latest Earnings
Date
Jul 30, 2026
ET
EPS Est.
1.82
EPS Actual
1.97
Revenue Est.
$2.4B
Revenue Actual
$2.51B
Next Earnings Report
Date
Nov 2, 2026 · Mon
Time
After-market
Fiscal Period
FY2026 Q3
EPS Est.
1.95
Revenue Est.
$2.43B
Company Overview
Eastman Chemical Company (ticker EMN) is listed on NYSE with a market cap of about $8.47B. Its next earnings report (FY2026 Q3) is expected on Nov 2, 2026 (ET), After-market, with consensus EPS of 1.95. In the last 15 reported quarters, EPS beat consensus estimates 11 times.
Actual EPS TrendRecently15Term · Jan 26, 2023 → Jul 30, 2026
Jan 26, 2023Range: 0.75 ~ 2.26Jul 30, 2026
Earnings History
| Date | Fiscal Period | EPS Est. | EPS Actual | Revenue Est. | Revenue Actual |
|---|---|---|---|---|---|
| Jul 30, 2026 | -- | 1.82 | 1.97 | $2.4B | $2.51B |
| Apr 30, 2026 | -- | 1.06 | 1.09 | $2.17B | $2.18B |
| Jan 29, 2026 | -- | 0.76 | 0.75 | $2.02B | $1.97B |
| Nov 3, 2025 | -- | 1.16 | 1.14 | $2.26B | $2.2B |
| Jul 31, 2025 | -- | 1.72 | 1.60 | $2.36B | $2.29B |
| Apr 24, 2025 | -- | 1.89 | 1.91 | $2.33B | $2.29B |
| Jan 30, 2025 | -- | 1.60 | Above forecast↑1.87 | $2.29B | $2.25B |
| Oct 31, 2024 | -- | 2.14 | 2.26 | $2.38B | $2.46B |
| Jul 25, 2024 | -- | 2.01 | 2.15 | $2.36B | $2.36B |
| Apr 25, 2024 | -- | 1.43 | 1.61 | $2.29B | $2.31B |
| Feb 1, 2024 | -- | 1.28 | 1.31 | $2.21B | $2.21B |
| Oct 26, 2023 | -- | 1.44 | 1.47 | $2.3B | $4.05B |
| Jul 27, 2023 | -- | 1.93 | 1.99 | $2.69B | $2.32B |
| Apr 27, 2023 | -- | 1.22 | Above forecast↑1.63 | $2.43B | $2.41B |
| Jan 26, 2023 | -- | 1.26 | Below forecast↓0.89 | $2.43B | $2.37B |
Original Filings (SEC)
10-Q2026-07-31 ↗
8-K2026-07-30 ↗
8-K2026-05-12 ↗
10-Q2026-05-01 ↗
8-K2026-04-30 ↗
8-K2026-02-20 ↗
10-K2026-02-13 ↗
8-K2026-01-29 ↗
Links point to the company's original filings on the U.S. Securities and Exchange Commission (SEC) website.
Report dates are US trading days (Eastern Time); EPS and revenue estimates are market consensus, in USD. This page is for reference only and does not constitute investment advice.
